Hematology NewsFDA grants zanubrutinib an accelerated approval in marginal zone lymphomaSeptember 16, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsCan reversing T-cell exhaustion benefit in B-cell lymphoma relapse?September 15, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves zanubrutinib in Waldenström’s macroglobulinemiaSeptember 7, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA warns of higher death risk with Pepaxto in multiple myelomaJuly 28, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves new asparaginase product for leukemiaJuly 20, 2021ALLLymphoma & Plasma Cell Disorders
Hematology NewsReal-world CAR T outcomes for DLBCL mimic clinical trialsJune 28, 2021DLBCLB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsExperimental antibody-drug conjugate shown active against r/r DLBCLJune 15, 2021B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
Hematology NewsChoosing the right R-CHOP dosage for elderly patients with DLBCLJune 8, 2021DLBCLB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsHigh-dose methotrexate of no CNS benefit for patients with high-risk DLBCLMay 18, 2021B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
Hematology NewsPediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsCNS/Brain CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsNo SPARKLE with ibrutinib plus chemo in r/r pediatric B-NHLMay 5, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeThe power and promise of social media in oncologyMay 3, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeHyperprogression on immunotherapy: When outcomes are much worseApril 30, 2021ImmunotherapyNonmelanoma Skin CancerMelanomaBreast CancerGastroenterologyGastrointestinal CancerGenitourinary Cancer
Hematology NewsFDA approves loncastuximab for diffuse large B-cell lymphomasApril 27, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFrontline brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphomaApril 21, 2021Hodgkin LymphomaLymphoma & Plasma Cell DisordersPediatrics
